NCT01697488View on ClinicalTrials.gov

An Observational Study of Avastin (Bevacizumab) in Combination With Carboplatin/Paclitaxel in First Line in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (OTILIA)

CompletedOBSERVATIONAL

Enrollment

1,090

Participants

Timeline

Start Date

February 2, 2012

Primary Completion Date

September 27, 2019

Study Completion Date

September 27, 2019

Conditions

Peritoneal Neoplasms

Trial Locations (1)

77652

Ortenau Klinikum Offenburg; Med. Klinik II; Mammachirurgie und Gynäkologisch-Onkologische Chirurgie, Offenburg

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT01697488 - An Observational Study of Avastin (Bevacizumab) in Combination With Carboplatin/Paclitaxel in First Line in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (OTILIA) | Biotech Hunter | Biotech Hunter